FDA-Inspected Site

Tanvex BioPharma USA, Inc

3 FDA inspections are on record for Tanvex BioPharma USA, Inc in San Diego, United States.

483· Form 483 issued

San Diego, United States · Last updated July 10, 2026

Overview

  • 3 FDA inspections are on record.
  • 3 inspections produced a Form 483.
  • The most recent recorded inspection date is 2023-01-24.

At a glance

Inspections

3

Form 483s

3

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
17 Jan 2023 – 24 Jan 2023Human Drugs483On file
25 Apr 2022 – 4 May 2022Human Drugs483On file
23 Apr 2019 – 2 May 2019Human Drugs483On file

Investigators

FDA investigators tied to this site in the record.

Full site report

Get the verbatim findings behind Tanvex BioPharma USA, Inc's 3 Form 483s

The full inspection record, as Atlas holds it, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat